The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 3,601–3,700 of 31,469
Wang, Y., Nie, M., Li, W., Ping, F., Hu, Y., Ma, L., Gao, J., & Liu, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026953 · Cited by 91
Trace Elements in Obese Turkish Children
Taşçılar, M. E., Özgen, İ. T., Abacı, A., Serdar, M. A., & Aykut, O. (2010) · Biological Trace Element Research · doi:10.1007/s12011-010-8878-8 · Cited by 90
Hermsdorff, H. H. M., Zulet, M. Á., Abete, I., & Martínez, J. A. (2009) · Endocrine · doi:10.1007/s12020-009-9248-1 · Cited by 90
Shalitin, S., Ashkenazi‐Hoffnung, L., Yackobovitch‐Gavan, M., Nagelberg, N., Karni, Y., Hershkovitz, E., Loewenthal, N., Shtaif, B., Gat‐Yablonski, G., & Phillip, M. (2009) · Hormone Research in Paediatrics · doi:10.1159/000245931 · Cited by 90
Tan, B. K., Chen, J., Lehnert, H., Kennedy, R., & Randeva, H. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0091 · Cited by 90
Nar, A., & Gedik, O. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0067-2 · Cited by 90
Inflammatory markers in relation to insulin resistance and the metabolic syndrome
Ingelsson, E., Hulthe, J., & Lind, L. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01962.x · Cited by 90
Vatansever, E., Sürmen-Gür, E., Ursavaş, A., & Karadağ, M. (2010) · Sleep And Breathing · doi:10.1007/s11325-010-0378-8 · Cited by 91
Siddiqui, M. S., Sterling, R. K., Luketic, V. A., Puri, P., Stravitz, R. T., Bouneva, I., Boyett, S. L., Fuchs, M. A., Sargeant, C., Warnick, G. R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.036 · Cited by 94
Zulian, E., Sartorato, P., Benedini, S., Baro, G., Armanini, D., Mantero, F., & Scaroni, C. M. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345529 · Cited by 91
Ramachandran, A., Snehalatha, C., Yamuna, A., Murugesan, N., & Narayan, K. M. V. (2007) · Diabetes Care · doi:10.2337/dc06-2097 · Cited by 90
Korish, A. A., & Arafah, M. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-264 · Cited by 90
Chiu, H. K., Tsai, E. C., Juneja, R., Stoever, J. A., Brooks‐Worrell, B., Goel, A., & Palmer, J. P. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.12.013 · Cited by 91
Effect of bariatric surgery on circulating chemerin levels
Ress, C., Tschoner, A., Engl, J., Klaus, A., Tilg, H., Ebenbichler, C. F., Patsch, J. R., & Kaser, S. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02255.x · Cited by 90
Weight Loss Increases 11β-Hydroxysteroid Dehydrogenase Type 1 Expression in Human Adipose Tissue
Tomlinson, J., Moore, J. S., Clark, P. M. S., Holder, G., Shakespeare, L., & Stewart, P. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031376 · Cited by 93
Ferguson, J. F., Phillips, C. M., Tierney, A. C., Pérez‐Martínez, P., Defoort, C., Helal, O., Lairon, D., Planells, R., Shaw, D. I., Lovegrove, J. A., et al. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28255 · Cited by 89
Continuous Glucose Monitoring for Evaluation of Glycemic Excursions after Gastric Bypass
Halperin, F., Patti, M., Skow, M., Bajwa, M. A., & Goldfine, A. B. (2011) · Journal of Obesity · doi:10.1155/2011/869536 · Cited by 91
Cahill, F., Shahidi, M., Shea, J. L., Wadden, D., Gulliver, W. P., Randell, E. W., Vasdev, S., & Sun, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058278 · Cited by 90
Sirtori, C. R., Triolo, M., Bosisio, R., Bondioli, A., Calabresi, L., Vergori, V. D., Gomaraschi, M., Mombelli, G. G., Pazzucconi, F., Zacherl, C., et al. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511004120 · Cited by 92
Caimari, A., Oliver, P., Keijer, J., & Palou, A. (2010) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2009.0092 · Cited by 90
Nickel exposure is associated with the prevalence of type 2 diabetes in Chinese adults
Liu, G., Sun, L., Pan, A., Zhu, M., Li, Z., Wang, Z., Liu, X., Ye, X., Li, H., Zheng, H., et al. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu200 · Cited by 92
Plasma Apelin and ADMA Levels in Patients with Essential Hypertension
Sönmez, A., Çelebi, G., Erdem, G., Tapan, S., Genç, H., Taşçı, İ., Erçin, C. N., Doğru, T., Kılıç, S., Üçkaya, G., et al. (2010) · Clinical and Experimental Hypertension · doi:10.3109/10641960903254505 · Cited by 90
Hovorka, R., Chassin, L. J., Luzio, S. D., Playle, R., & Owens, D. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4646 · Cited by 90
Ronchi, C. L., Varca, V., Beck‐Peccoz, P., Orsi, E., Donadio, F., Baccarelli, A., Giavoli, C., Ferrante, E., Lania, A. G., Spada, A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1704 · Cited by 90
A practical approach to the diagnosis of polycystic ovary syndrome
Chang, R. J. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.04.045 · Cited by 89
Dinh, W., Lankisch, M., Nickl, W., Scheyer, D., Scheffold, T., Kramer, F., Krahn, T., Klein, R. M., Barroso, M. C., & Füth, R. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-63 · Cited by 87
Samman, S., Sivarajah, G., Man, J. C., Ahmad, Z. I., Caterson, I. D., & Petocz, P. (2003) · Journal of Nutrition · doi:10.1093/jn/133.7.2188 · Cited by 89
Vancheri, F., Curcio, M., Burgio, A., Salvaggio, S., Gruttadauria, G., Lunetta, M., Dovico, R., & Alletto, M. (2005) · QJM · doi:10.1093/qjmed/hci134 · Cited by 90
Goodarzi, M. O., Shah, N. A., Antoine, H. J., Pall, M., Guo, X., & Azziz, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0227 · Cited by 90
Yılmaz, M. İ., Carrero, J. J., Ortíz, A., Martı́n-Ventura, J. L., Sönmez, A., Sağlam, M., Yaman, H., Yenicesu, M., Egido, J., & Blanco‐Colio, L. M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02760409 · Cited by 89
Biological Signatures of Asymptomatic Extra- and Intracranial Atherosclerosis
López‐Cancio, E., Galán, A., Dorado, L., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.661702 · Cited by 90
Hanley, A. J., Retnakaran, R. R., Qi, Y., Gerstein, H. C., Perkins, B. A., Raboud, J., Harris, S. B., & Zinman, B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0719 · Cited by 90
Lotta, L. A., Abbasi, A., Sharp, S. J., Sahlqvist, A., Waterworth, D. M., Brosnan, J. M., Scott, R. A., Langenberg, C., & Wareham, N. J. (2015) · Diabetes Care · doi:10.2337/dc15-1218 · Cited by 89
A Low-Glycemic-Load versus Low-Fat Diet in the Treatment of Fatty Liver in Obese Children
Ramon‐Krauel, M., Salsberg, S., Ebbeling, C. B., Voss, S. D., Mulkern, R. V., Apura, M. M., Cooke, E. A., Sarao, K., Jonas, M. M., & Ludwig, D. S. (2013) · Childhood Obesity · doi:10.1089/chi.2013.0022 · Cited by 94
Cystic fibrosis‐related diabetes: the role of peripheral insulin resistance and β‐cell dysfunction
Yung, B., Noormohamed, F. H., Kemp, M., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00666.x · Cited by 90
Weight Loss Reduces Circulating Asymmetrical Dimethylarginine Concentrations in Morbidly Obese Women
Krzyżanowska, K., Mittermayer, F., Kopp, H.-P., Wolzt, M., & Schernthaner, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0672 · Cited by 89
Rasmussen, S. K., Urhammer, S. A., Pizzuti, A., Echwald, S. M., Ekstrøm, C. T., Hansen, L., Hansen, T. F., Borch‐Johnsen, K., Frittitta, L., Trischitta, V., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.9.1608 · Cited by 88
Meyer, A. A., Joharchi, M. S., Kundt, G., Schuff‐Werner, P., Steinhoff, G., & Kienast, W. (2004) · European Heart Journal · doi:10.1093/eurheartj/ehi037 · Cited by 90
Insulin, intact and split proinsulin, and coronary artery disease in young men.
Båvenholm, P., Proudler, A., Tornvall, P., Godsland, I., Landou, C., de Faire, U., & Hamsten, A. (1995) · Circulation · doi:10.1161/01.cir.92.6.1422 · Cited by 109
How to measure insulin action in vivo
Scheen, A. J., Paquot, N., Castillo, M. J., & Lefèbvre, P. J. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100206 · Cited by 90
Larsen, S., Ara, I., Rabøl, R., Andersen, J. L., Boushel, R., Dela, F., & Helge, J. W. (2009) · Diabetologia · doi:10.1007/s00125-009-1353-4 · Cited by 90
Actos Now for the prevention of diabetes (ACT NOW) study
DeFronzo, R. A., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S., Henry, R. R., Kitabchi, A. E., Mudaliar, S., Musi, N., Ratner, R., et al. (2009) · BMC Endocrine Disorders · doi:10.1186/1472-6823-9-17 · Cited by 89
Omental and subcutaneous adipose tissue steroid levels in obese men
Bélanger, C., Hould, F.-S., Lebel, S., Biron, S., Brochu, G., & Tchernof, A. (2006) · Steroids · doi:10.1016/j.steroids.2006.04.008 · Cited by 89
Habitual sleep as a contributor to racial differences in cardiometabolic risk
Curtis, D. S., Fuller-Rowell, T. E., El-Sheikh, M., Carnethon, M. R., & Ryff, C. D. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618167114 · Cited by 89
Donà, G., Sabbadin, C., Fiore, C., Bragadin, M., Giorgino, F. L., Ragazzi, E., Clari, G., Bordin, L., & Armanini, D. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0840 · Cited by 89
Wang, J., Light, K., Henderson, M., O’Loughlin, J., Mathieu, M.-E., Paradis, G., & Gray-Donald, K. (2014) · The Journal of Nutrition · doi:10.3945/jn.113.182519 · Cited by 88
Dadmanesh, M., Aghajani, H., Fadaei, R., & Ghorban, K. (2018) · PLOS ONE · doi:10.1371/journal.pone.0204180 · Cited by 89
Rideout, T. C., Marinangeli, C. P. F., Martin, H., Browne, R. W., & Rempel, C. B. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-56 · Cited by 89
Association of Serum Ferritin and the Development of Metabolic Syndrome in Middle-Aged Korean Men
Park, S. K., Ryoo, J., Kim, M. G., & Shin, J. (2012) · Diabetes Care · doi:10.2337/dc12-0543 · Cited by 88
The Hypertension–Diabetes Continuum
Cheung, B. M. Y. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181d26430 · Cited by 89
Gómez‐Ambrosi, J., Catalán, V., Rodrı́guez, A., Ramírez, B., Silva, C., Gil, M. J., Salvador, J., & Frühbeck, G. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.05.004 · Cited by 89
Chedraui, P. A., Pérez-López, F. R., Escobar, G. S., Palla, G., Guevara, M. M. M., Cecchi, E., Genazzani, A. R., & Simoncini, T. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.06.008 · Cited by 91
Short-Term Changes after a Weight Reduction Intervention in Advanced Diabetic Nephropathy
Friedman, A. N., Chambers, M., Kamendulis, L. M., & Temmerman, J. C. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04010413 · Cited by 91
Human obesity relationship with Ad36 adenovirus and insulin resistance
Trovato, G. M., Castro, A., Tonzuso, A., Garozzo, A., Martines, G. F., Pirri, C., Trovato, F. M., & Catalano, D. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.196 · Cited by 90
Karl, J. P., Meydani, M., Barnett, J. B., Vanegas, S. M., Goldin, B., Kane, A., Rasmussen, H., Saltzman, E., Vangay, P., Knights, D., et al. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.139683 · Cited by 89
Lai, S., Muscaritoli, M., Andreozzi, P., Sgreccia, A., Leo, S. D., Mazzaferro, S., Mitterhofer, A. P., Pasquali, M., Protopapa, P., Spagnoli, A., et al. (2018) · Nutrition · doi:10.1016/j.nut.2018.12.005 · Cited by 89
New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion
Farino, Z. J., Morgenstern, T. J., Maffei, A., Quick, M., Solís, A. J. D., Wiriyasermkul, P., Freyberg, R. J., Aslanoglou, D., Sorisio, D. A., Inbar, B., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0344-6 · Cited by 99
Ruddick-Collins, L. C., Morgan, P. J., Fyfe, C., Filipe, J. A. N., Horgan, G. W., Westerterp, K. R., Johnston, J. D., & Johnstone, A. M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.08.001 · Cited by 91
Yu, M., Wei, X., Wei, Z., Song, G., Zhao, X., & Lei, Y. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02287-y · Cited by 92
Boonloh, K., Kukongviriyapan, V., Kongyingyoes, B., Kukongviriyapan, U., Thawornchinsombut, S., & Pannangpetch, P. (2015) · Nutrients · doi:10.3390/nu7085292 · Cited by 89
Otgonsuren, M., Estep, M. J., Hossain, N., Younossi, E., Frost, S., Henry, L. L., Hunt, S., Fang, Y. H., Goodman, Z. D., & Younossi, Z. M. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12665 · Cited by 90
Metabolic syndrome in drug-naïve and drug-free patients with schizophrenia and in their siblings
Darçın, A. E., Çavuş, S. Y., Dılbaz, N., Kaya, H., & Dogan, E. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.05.004 · Cited by 89
Manzella, D. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.11.006 · Cited by 89
Yorifuji, T., Fujimaru, R., Hosokawa, Y., Tamagawa, N., Shiozaki, M., Aizu, K., Jinno, K., Maruo, Y., Nagasaka, H., Tajima, T., et al. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00827.x · Cited by 89
Li-ya, W., Piotrowski, K., Rau, T., Waldmann, E., Broedl, U. C., Demmelmair, H., Koletzko, B. V., Stark, R. G., Nagel, J. M., Mantzoros, C. S., et al. (2013) · Metabolism · doi:10.1016/j.metabol.2013.11.005 · Cited by 91
Shalitin, S., Yackobovitch‐Gavan, M., & Phillip, M. (2009) · Hormone Research in Paediatrics · doi:10.1159/000197872 · Cited by 88
Shalitin, S., Abrahami, M., Lilos, P., & Phillip, M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802919 · Cited by 89
The Effects of the Dietary Glycemic Load on Type 2 Diabetes Risk Factors during Weight Loss
Pittas, A. G., Roberts, S. B., Das, S. K., Gilhooly, C. H., Saltzman, E. J., Golden, J. K., Stark, P. C., & Greenberg, A. S. (2006) · Obesity · doi:10.1038/oby.2006.258 · Cited by 92
Peppa, Μ., Boutati, E. I., Koliaki, C. C., Papaefstathiou, N., Garoflos, E., Economopoulos, T., Hadjidakis, D., & Raptis, S. (2010) · Metabolism · doi:10.1016/j.metabol.2010.01.007 · Cited by 89
Villarreal-Molina, M. T., Posadas‐Romero, C., Romero‐Hidalgo, S., Antúnez-Argüelles, E., Bautista-Grande, A., Vargas‐Alarcón, G., Kimura‐Hayama, E., Canizales‐Quinteros, S., Juárez-Rojas, J. G., Posadas‐Sánchez, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049285 · Cited by 90
Yoon, S. H., Han, E. J., Sung, J. H., & Chung, S. H. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.2196 · Cited by 90
Physical Activity, Obesity Status, and Glycemic Control
Kavouras, S. A., Panagiotakos, D. B., Pitsavos, C. E., Chrysohoou, C. A., Anastasiou, C. A., Lentzas, Y., & Stefanadis, C. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31803084eb · Cited by 93
Järvelä, L. S., Kemppainen, J., Niinikoski, H., Hannukainen, J. C., Lähteenmäki, P. M., Kapanen, J., Arola, M. O., & Heinonen, O. J. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.24049 · Cited by 89
Holt, R. I. G., Phillips, D. I. W., Jameson, K. A., Cooper, C. C., Dennison, E. M., Peveler, R., & The Hertfordshire Cohort Study Group (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02742.x · Cited by 92
Doğru, T., Genç, H., Tapan, S., Aslan, F., Erçin, C. N., Örs, F., Kara, M., Sertoğlu, E., Karslıoğlu, Y., Bağcı, S., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04460.x · Cited by 90
Trimis, G. G., Moschovi, M. A., Papassotiriou, I., Chrousos, G. P., & Tzortzatou-Stathopoulou, F. F. (2007) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e318059c249 · Cited by 89
Elevated Cystatin C Concentration and Progression to Pre-Diabetes
Donahue, R. P., Stranges, S., Rejman, K., et al. (2007) · Diabetes Care · doi:10.2337/dc07-0040 · Cited by 89
Non‐alcoholic steatohepatitis in children
Kerkar, N. N. (2004) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2004.00241.x · Cited by 89
Alkhouri, N., Mansoor, S., Giammaria, P., Liccardo, D., López, R., & Nobili, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104558 · Cited by 89
Kent, S. C., Gnatuk, C. L., Kunselman, A. R., Demers, L. M., Lee, P. A., & Legro, R. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1958 · Cited by 91
Magliano, D. C., Bargut, T. C. L., de Carvalho, S. N., Águila, M. B., Mandarim‐de‐Lacerda, C. A., & Souza‐Mello, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064258 · Cited by 89
Maternal and fetal adropin levels in gestational diabetes mellitus
Çelik, E., Yılmaz, E., Çelik, Ö., et al. (2013) · Journal of Perinatal Medicine · doi:10.1515/jpm-2012-0227 · Cited by 89
Morrison, J. A., Glueck, C. J., Horn, P. S., Schreiber, G. B., & Wang, P. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.3.778 · Cited by 89
Kellow, N. J., Coughlan, M. T., Savige, G. S., & Reid, C. M. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-55 · Cited by 93
Morgante, G., Tosti, C., Orvieto, R., Musacchio, M. C., Piomboni, P., & Leo, V. D. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.009 · Cited by 89
Mirza, N. M., Palmer, M., Sinclair, K. B., McCarter, R., He, J., Ebbeling, C. B., Ludwig, D. S., & Yanovski, J. A. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.042630 · Cited by 88
Corpeleijn, E., Kallen, C., Kruijshoop, M., Magagnin, M. G., de Bruin, T. W., Feskens, E. J. M., Saris, W. H. M., & Blaak, E. E. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01888.x · Cited by 89
Fleischhacker, W. W., SIU, C. O., Bodén, R., Pappadopulos, E. A., Karayal, O. N., Kahn, R. S., & the EUFEST study group (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001241 · Cited by 92
A Prospective Analysis of Elevated Fasting Glucose Levels and Cognitive Function in Older People
Euser, S. M., Sattar, N. A., Witteman, J. C. M., Bollen, E. L. E. M., Sijbrands, E. J. G., Albert Hofman, D., Perry, I. J., Breteler, M. M. B., Westendorp, R. G. J., & Study, F. P. A. T. R. (2010) · Diabetes · doi:10.2337/db09-0568 · Cited by 89
Lovegrove, J. A., Lovegrove, S. S., Lesauvage, S. V., Brady, L. M., Saini, N., Minihane, A. M., & Williams, C. M. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.974 · Cited by 88
Circulating Insulin-Like Growth Factor-1 and Its Binding Protein-3
Lam, C. S. P., Chen, M., Lacey, S. M., Yang, Q., SULLIVAN, L. M., Xanthakis, V., Safa, R., Smith, H., Peng, X., Sawyer, D. B., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.203943 · Cited by 91
Chen, L., Xu, W., & Zhang, D. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.06.027 · Cited by 89
Lara, J. J., Economou, M., Wallace, A. M., Rumley, A., Lowe, G. D. O., Slater, C., CASLAKE, M. J., Sattar, N. A., & Lean, M. E. J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.06.018 · Cited by 89
de Courten, B. V., de Courten, M., Hanson, R. L., Zahorakova, A., Egyenes, H. P., Tataranni, P. A., Bennett, P. H., & Vozár, J. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00162-1 · Cited by 89
Choquette, S., Riesco, É., Cormier, É., Dion, T., Aubertin‐Leheudre, M., & Dionne, I. J. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510004897 · Cited by 92
Bosch, T. A., Dengel, D. R., Kelly, A. S., Sinaiko, A. R., Moran, A., & Steinberger, J. (2014) · Pediatric Obesity · doi:10.1111/ijpo.249 · Cited by 89
Trøseid, M., Seljeflot, I., Hjerkinn, E. M., & Arnesen, H. (2008) · Diabetes Care · doi:10.2337/dc08-1710 · Cited by 89
Dietary intakes associated with metabolic syndrome in a cohort of Japanese ancestry
Damião, R., de Castro, T. G., Cardoso, M. A., Gimeno, S. G. A., Ferreira, S. R. G., & for the Japanese–Brazilian Diabetes Study Group (2006) · British Journal Of Nutrition · doi:10.1079/bjn20061876 · Cited by 86
Maithilikarpagaselvi, N., Sridhar, M. G., Swaminathan, R. P., & Bobby, Z. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.12.012 · Cited by 94
Zeba, A. N., Delisle, H. F., Renier, G., Savadogo, B., & Baya, B. (2012) · Public Health Nutrition · doi:10.1017/s1368980012000729 · Cited by 86
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
